Lu Hong S, Daugherty Alan
Saha Cardiovascular Research Center, University of Kentucky, Lexington, KY, United States.
Saha Aortic Center, University of Kentucky, Lexington, KY, United States.
Front Cardiovasc Med. 2022 Mar 9;9:856102. doi: 10.3389/fcvm.2022.856102. eCollection 2022.
To respond to the NIH's policy for rigor and reproducibility in preclinical research, many journals have implemented guidelines and checklists to guide authors in improving the rigor and reproducibility of their research. Transparency in developing detailed prospective experimental designs and providing raw data are essential premises of rigor and reproducibility. Standard peer reviews and journal-specific technical and statistical reviews are critical factors for enhancing rigor and reproducibility. This brief review also shares some experience from , an American Heart Association journal, that has implemented several mechanisms to enhance rigor and reproducibility for preclinical research.
为响应美国国立卫生研究院(NIH)关于临床前研究严谨性和可重复性的政策,许多期刊已实施指南和清单,以指导作者提高其研究的严谨性和可重复性。制定详细的前瞻性实验设计和提供原始数据的透明度是严谨性和可重复性的基本前提。标准的同行评审以及特定期刊的技术和统计评审是提高严谨性和可重复性的关键因素。本简要综述还分享了美国心脏协会期刊的一些经验,该期刊已实施了多种机制来提高临床前研究的严谨性和可重复性。